verteporfin 15 MG Injection
Managing this medication for someone you care for? Eleplan keeps diagnoses, medications and appointments in one plan.
Start free with EleplanClinical drug
verteporfin 15 MG Injection
15 MG · Injection · injection
A form of verteporfin →
verteporfin 15 MG Injection — Antineovascularisation agents. Strength, form, class, interactions & more.
Active ingredient
Classification
Antineovascularisation agentsPhotoenhancer
Drug interactions
Verteporfin may interact with various drugs and substances, potentially affecting its efficacy and safety.
- moderatecalcium channel blockers — could enhance the rate of VISUDYNE uptake by the vascular endothelium
- moderatepolymyxin B — could enhance the rate of VISUDYNE uptake by the vascular endothelium
- moderateradiation therapy — could enhance the rate of VISUDYNE uptake by the vascular endothelium
- moderatetetracyclines — could increase the potential for skin photosensitivity reactions
- moderatesulfonamides — could increase the potential for skin photosensitivity reactions
- moderatephenothiazines — could increase the potential for skin photosensitivity reactions
- moderatesulfonylurea hypoglycemic agents — could increase the potential for skin photosensitivity reactions
- moderatethiazide diuretics — could increase the potential for skin photosensitivity reactions
- moderategriseofulvin — could increase the potential for skin photosensitivity reactions
- moderatedimethyl sulfoxide — would be expected to decrease VISUDYNE activity
- moderateβ-carotene — would be expected to decrease VISUDYNE activity
- moderateethanol — would be expected to decrease VISUDYNE activity
- moderateformate — would be expected to decrease VISUDYNE activity
- moderatemannitol — would be expected to decrease VISUDYNE activity
- moderatethromboxane A2 inhibitors — could decrease the efficacy of VISUDYNE therapy
Source: RxNorm + openFDA + RxClass + FAERS · 2026
Look up another medication